Literature DB >> 29308455

Manifold Learning of COPD.

Felix J S Bragman1, Jamie R McClelland1, Joseph Jacob1, John R Hurst2, David J Hawkes1.   

Abstract

Analysis of CT scans for studying Chronic Obstructive Pulmonary Disease (COPD) is generally limited to mean scores of disease extent. However, the evolution of local pulmonary damage may vary between patients with discordant effects on lung physiology. This limits the explanatory power of mean values in clinical studies. We present local disease and deformation distributions to address this limitation. The disease distribution aims to quantify two aspects of parenchymal damage: locally diffuse/dense disease and global homogeneity/heterogeneity. The deformation distribution links parenchymal damage to local volume change. These distributions are exploited to quantify inter-patient differences. We used manifold learning to model variations of these distributions in 743 patients from the COPDGene study. We applied manifold fusion to combine distinct aspects of COPD into a single model. We demonstrated the utility of the distributions by comparing associations between learned embeddings and measures of severity. We also illustrated the potential to identify trajectories of disease progression in a manifold space of COPD.

Entities:  

Year:  2017        PMID: 29308455      PMCID: PMC5749261          DOI: 10.1007/978-3-319-66179-7_6

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  8 in total

1.  A global geometric framework for nonlinear dimensionality reduction.

Authors:  J B Tenenbaum; V de Silva; J C Langford
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

2.  MIND: modality independent neighbourhood descriptor for multi-modal deformable registration.

Authors:  Mattias P Heinrich; Mark Jenkinson; Manav Bhushan; Tahreema Matin; Fergus V Gleeson; Sir Michael Brady; Julia A Schnabel
Journal:  Med Image Anal       Date:  2012-05-31       Impact factor: 8.545

3.  Fast free-form deformation using graphics processing units.

Authors:  Marc Modat; Gerard R Ridgway; Zeike A Taylor; Manja Lehmann; Josephine Barnes; David J Hawkes; Nick C Fox; Sébastien Ourselin
Journal:  Comput Methods Programs Biomed       Date:  2009-10-08       Impact factor: 5.428

4.  A combined manifold learning analysis of shape and appearance to characterize neonatal brain development.

Authors:  P Aljabar; R Wolz; L Srinivasan; S J Counsell; M A Rutherford; A D Edwards; J V Hajnal; D Rueckert
Journal:  IEEE Trans Med Imaging       Date:  2011-07-22       Impact factor: 10.048

5.  Genetic epidemiology of COPD (COPDGene) study design.

Authors:  Elizabeth A Regan; John E Hokanson; James R Murphy; Barry Make; David A Lynch; Terri H Beaty; Douglas Curran-Everett; Edwin K Silverman; James D Crapo
Journal:  COPD       Date:  2010-02       Impact factor: 2.409

6.  Multi-scale analysis of imaging features and its use in the study of COPD exacerbation susceptible phenotypes.

Authors:  Felix J S Bragman; Jamie R McClelland; Marc Modat; Sébastien Ourselint; John R Hurst; David J Hawkes
Journal:  Med Image Comput Comput Assist Interv       Date:  2014

7.  A Robust Emphysema Severity Measure Based on Disease Subtypes.

Authors:  Rola Harmouche; James C Ross; Alejandro A Diaz; George R Washko; Raul San Jose Estepar
Journal:  Acad Radiol       Date:  2016-03-02       Impact factor: 3.173

8.  Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression.

Authors:  Craig J Galbán; Meilan K Han; Jennifer L Boes; Komal A Chughtai; Charles R Meyer; Timothy D Johnson; Stefanie Galbán; Alnawaz Rehemtulla; Ella A Kazerooni; Fernando J Martinez; Brian D Ross
Journal:  Nat Med       Date:  2012-10-07       Impact factor: 53.440

  8 in total
  1 in total

1.  Disease Progression Modeling in Chronic Obstructive Pulmonary Disease.

Authors:  Alexandra L Young; Felix J S Bragman; Bojidar Rangelov; MeiLan K Han; Craig J Galbán; David A Lynch; David J Hawkes; Daniel C Alexander; John R Hurst
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.